Guangzhou Pharma May Form China Generics JV with Teva Pharma

Guangzhou Pharma may partner with Teva Pharma, the world's largest generic drugmaker, to form a JV that would bring the Israeli company's generics to China , according to a Bloomberg article. Teva refused to confirm the JV plans, but it didn't deny them either. The two companies already have a relationship: Guangzhou Pharma is awaiting China approval of several Teva generics. Teva does not currently have a major China presence, a surprise given the company's size and generic drug offerings. More details.... Stock Symbol: (NYSE: TEVA) Share this with colleagues: // //
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.